Featured Post

What’s your ICH E6(R3) Readiness Score?

The new ICH E6(R3) GCP guideline, impacting clinical studies starting 23 July 2025, introduces significantly more detailed requirements around the integrity and governance of data assets and trial records, including...

Read More

  • Filter By:

Register for updates

Learn how we can support your programs

Contact Us

QuartzBio Logo_The Precision Medicine Intelligence Company _white

Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments. Precision for Medicine is part of Precision Medicine Group, with 3,000 employees in 40 locations.

QUARTZBIO® and the PRECISION QUARTZBIO® logo are registered trademarks of Precision Medicine Group, LLC in the United States and/or other jurisdictions. All rights reserved.

© 2024. All rights reserved.
Precision Medicine Group, LLC.
Privacy Policy | GDPR

Web Design and Development by RainCastle Communications.